Mrs. Dianna Hack Hart, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8915 Millwood Dr, Spotsylvania, VA 22551 Phone: 540-226-3061 |
Anne Hwang Blair, LCSW Clinical Social Worker Medicare: May Accept Medicare Assignments Practice Location: 7424 Brock Rd, Spotsylvania, VA 22553 Phone: 540-582-3980 |
Alyssa A Goodman, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7565 Courthouse Rd, Spotsylvania, VA 22551 Phone: 540-582-7583 |
Hillary C Wakefield, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 7424 Brock Rd, Spotsylvania, VA 22553 Phone: 540-582-3980 Fax: 540-371-3753 |
Paulette E Bryan, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7424 Brock Rd, Spotsylvania, VA 22553 Phone: 540-582-3980 Fax: 540-371-3753 |
O'dale D Laws, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7424 Brock Rd, Spotsylvania, VA 22553 Phone: 540-582-3980 Fax: 540-371-3753 |
Ms. Donna Jones, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10612 Cobblestone Dr, Spotsylvania, VA 22553 Phone: 540-907-6279 |
Mrs. Melissa Haney Dannemiller, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 7424 Brock Rd, Spotsylvania, VA 22553 Phone: 540-582-3980 |
News Archive
Two children arrived on a flight from Mexico to Denver showing symptoms of the contagious illness called ‘hand, foot and mouth' disease (HFMD) and were checked by paramedics. They were allowed to leave after experts said they were no threat to public health.
The protease inhibitor lopinavir - the primary component of Abbott Laboratories' antiretroviral drug Kaletra - selectively killed the human papillomavirus in laboratory tests, according to a study scheduled to be published next month in the journal Anti-Viral Therapy.
Researchers in Singapore have conducted a study showing that the messenger RNA- (mRNA) based coronavirus disease 2019 (COVID-19) vaccines developed by Pfizer-BioNTech and Moderna are highly effective at protecting against symptomatic and severe disease following infection with the rapidly spreading B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
A recent proof-of-concept study finds that a low-cost training program can reduce hazardous driving in older adults. Researchers hope the finding will lead to the training becoming more widely available.
Australian researchers have made a critical discovery about a gene involved in muscular dystrophy that could lead to future therapies for the currently untreatable disease.
› Verified 8 days ago